Alexander Drilon, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the importance of central nervous system (CNS) activity in agents for the treatment of non–small cell lung cancer (NSCLC).
Updates to NCCN Guidelines for CNS Cancers Pinpoint the Importance of Testing
May 21st 2023In an interview with Targeted Oncology, Craig Horbinski, MD, PhD, discussed recent recommendations and NCCN guidelines regarding the molecular profiling of gliomas and other central nervous system cancers.
Read More
2 Clarke Drive
Cranbury, NJ 08512